The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review.
ABC pathway
Atrial fibrillation
Integrated care
Management
Patients
Review
Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649
Informations de publication
Date de publication:
09 10 2021
09 10 2021
Historique:
received:
19
01
2021
accepted:
31
03
2021
pubmed:
15
6
2021
medline:
21
10
2021
entrez:
14
6
2021
Statut:
ppublish
Résumé
The 2020 European Society of Cardiology guidelines endorse the Atrial Fibrillation Better Care (ABC) pathway as a structured approach for the management of atrial fibrillation (AF), addressing three principal elements: 'A' - avoid stroke (with oral anticoagulation), 'B' - patient-focused better symptom management, and 'C' - cardiovascular and comorbidity risk factor reduction and management. This review summarizes the definitions used for the ABC criteria in different studies and the impact of adherence/non-adherence on clinical outcomes, from 12 studies on seven different cohorts. All studies consistently showed statistically significant reductions in the risk of stroke, myocardial infarction, and mortality among those with ABC pathway adherent treatment. The ABC pathway provides a simple decision-making framework to enable consistent equitable care from clinicians in primary and secondary/tertiary care. Further research examining the impact of ABC pathway implementation in prospective cohorts utilizing consistent inclusion criteria and definitions of 'A', 'B', and 'C' adherent care is warranted.
Identifiants
pubmed: 34125202
pii: 6298528
doi: 10.1093/europace/euab092
pmc: PMC8502499
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1511-1527Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
J Arrhythm. 2020 Jun 05;36(4):668-677
pubmed: 32782638
Lancet. 2017 Oct 21;390(10105):1873-1887
pubmed: 28460828
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Am J Med. 2018 Nov;131(11):1359-1366.e6
pubmed: 30153428
Eur Heart J. 2018 Sep 1;39(33):3007-3008
pubmed: 30990869
Pol Arch Intern Med. 2020 Mar 27;130(3):187-195
pubmed: 31969552
Eur Heart J. 2012 Nov;33(21):2692-9
pubmed: 22453654
Thromb Haemost. 2017 Jun 28;117(7):1230-1239
pubmed: 28597905
J Am Heart Assoc. 2016 Jan 25;5(1):
pubmed: 26811169
Blood Press. 2014 Feb;23(1):3-16
pubmed: 24359485
J Clin Med. 2020 Apr 29;9(5):
pubmed: 32365582
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Eur Heart J. 2013 Oct;34(39):3035-87
pubmed: 23996285
Eur Heart J. 2012 Jul;33(14):1787-847
pubmed: 22611136
Eur J Clin Invest. 2021 Mar;51(3):e13385
pubmed: 32810282
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Thromb Haemost. 2019 Oct;119(10):1695-1703
pubmed: 31266082
Europace. 2018 Mar 1;20(3):395-407
pubmed: 29300976
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Milbank Q. 1996;74(4):511-44
pubmed: 8941260
Nat Rev Cardiol. 2017 Nov;14(11):627-628
pubmed: 28960189
Eur J Intern Med. 2020 Dec;82:105-111
pubmed: 33067121
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Europace. 2021 Feb 5;23(2):174-183
pubmed: 33006613
J Am Heart Assoc. 2020 May 18;9(10):e014932
pubmed: 32370588
J Clin Med. 2020 Jun 02;9(6):
pubmed: 32498299
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Heart. 2017 Dec;103(24):1947-1953
pubmed: 28490616
Mayo Clin Proc. 2019 Jul;94(7):1261-1267
pubmed: 30551910
J Am Coll Cardiol. 2020 Apr 7;75(13):1523-1534
pubmed: 32241367
Lancet. 2015 Feb 28;385(9970):775-84
pubmed: 25467562
Can J Cardiol. 2019 May;35(5):611-618
pubmed: 31030863
Am J Med. 2016 Dec;129(12):1278-1287
pubmed: 27476087